Fasting Induced Hypoglycaemia in Anaesthetised Paediatric Patients

NCT ID: NCT07259629

Last Updated: 2025-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

6580 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-12

Study Completion Date

2027-01-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fasting is a requirement to safely anesthetise patients referred for elective procedure, using the traditional 6/4/2 rule (6h for solid food or formula milk, 4h for breast milk and 2h for clear fluids), applied to all patients regardless of their age or weight. Reducing the aspiration risk however puts young children at higher risk of hypoglycemia due to the immaturity of their endocrine system and absence of metabolic reserves. The Association of Paediatric Anaesthetists of Great Britain and Ireland recommends that during day case surgery the majority of children may be given fluids without dextrose, provided blood glucose is monitored. Recent statements recommend continuing fluids until 1h before the procedure or even to give fluids when anesthetists sent for the patients. Hypoglycemia is rare in children above 2 years of age. Although the definition of hypoglycemia can differ, a threshold of 3.6mmol/l is often used given the potential neurological harm existing below this value. There is no consensus on the definition of hypoglycemia in children being fasted prior to general anesthesia, nor when nor how to treat it. Measurements are done for complex surgeries or patients deemed at risk according to the anesthetists. An audit was run in 2017 at the " Evelina London Children's Hospital ", Guy's and St Thomas' National Health Service Foundation Trust, identifying 8% of children below 2 years of age as hypoglycemic. Recent review of our Incident Reporting Systems identified 3 cases, in otherwise fit and healthy children, referred for colonoscopy with initial hypoglycemia followed by rebound hypoglycemia after management. There is an urgent need to establish a clear definition of hypoglycemia and investigate risk factors in paediatric patients referred for elective procedures under general anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypoglycemia; Iatrogenic Anesthesia Pediatrics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All American Society of Anesthesiology score (ASA) 1 - 3 children aged 1 month to 18 years presenting for an elective procedure involving general anaesthesia during the defined study period
* All elective cases, day cases will be included (patient's admitted the night before for bowel preparation prior to elective colonoscopy should also be included)
* Planned expedited cases in ASA 1 / 2 children should be included, for example nail bed repairs, lacerations, foreign body (in ear / eye / nose), simple fractures for manipulation under anesthesia / k-wires
* MRI, radiology and dental cases will be included provided the patient receives a general anaesthetic

Exclusion Criteria

* Children aged less than 1 month
* Procedures performed under oral sedation or local anaesthesia only
* ASA status 4 and 5
* Children with any endocrine or metabolic condition or who have a fasting plan prior to general anaesthesia for glucose control:
* Type 1 or 2 diabetes mellitus, medium chain acetyl Co-enzyme A, maple syrup urine disease, glycogen storage disease, galactosaemia, urea cycle defects, familial hypercholesterolaemia, congenital disorders of glycosylation, lysosomal storage disorders, organic acidaemias, mitochondrial disorders, adrenal gland disorders, adrenoleukodystrophy, growth disorders, lipid disorders, multiple endocrine neoplasia type 1 and 2, pituitary disorders.
* Emergency and oncology procedures as these children will have different risk factors for hypoglycaemia
* Anaesthetic involvement in critically ill children e.g. airway management in emergency department, pediatric intensive care unit
* Children on glucose containing intravenous solutions or total parenteral nutrition pre-operatively
* Children on systemic steroid treatment (oral / intravenous). Children on inhalers / topical steroids should be included
Minimum Eligible Age

1 Month

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Evelina London Children's Charity

UNKNOWN

Sponsor Role collaborator

Nova Biomedical

INDUSTRY

Sponsor Role collaborator

Kings Health Partners

OTHER

Sponsor Role collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Royal Devon University Healthcare NHS Foundation Trust

Exeter, Devon, United Kingdom

Site Status RECRUITING

Moorfields Eye Hospital

London, , United Kingdom

Site Status COMPLETED

Evelina London Children's Hospital

London, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Benjamin Blaise, MD PhD

Role: CONTACT

+447478741874

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Philippa Dix, FRCA

Role: primary

+441392411611

Benjamin Blaise Blaise, MD PhD

Role: primary

+447478741874

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

329701

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lactate to Treat Hypoglycemia
NCT01387477 WITHDRAWN PHASE4
Starvation in the Treatment of Diabetic Ketoacidosis
NCT06186245 ENROLLING_BY_INVITATION NA